Skip to content

Extracorporeal Shockwave on Abdominal Adiposity and Lipid Profile

Effect of Extracorporeal Shockwave on Abdominal Adiposity and Lipid Profile in Obese Postmenopausal Women

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06290674
Enrollment
60
Registered
2024-03-04
Start date
2022-09-11
Completion date
2024-02-01
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Abdominal

Brief summary

Almost postmenopausal women store significant extra visceral adipose tissue with unexplained mechanism, yet. Postmenopausal obese women with excess abdominal obesity have raised metabolic risk of numerous cardiovascular diseases, which negatively influence health policy concern. Therefore, actual need to recommend non-invasive approach that cover this lack of quantitative knowledge in clinical management of obese postmenopausal women.

Detailed description

Postmenopausal women are usually troubled by increasing weight and waist circumference caused by obesity and androcidal fat redistribution. Abdominal adiposity, defined as a waist circumference ≥88cm in women, measured in the upright position, plus significant elevated lipid profile values. In postmenopausal women, a higher level of physical activity was associated with a more optimal body composition, including lower adiposity and higher lean mass. Management of abdominal obesity involves different techniques i.e., dietary management, exercise therapy, even lifestyle management, and pharmacological management, and surgical interventions. Extracorporeal shockwave provides cavitation phenomena that may facilitate better management of abdominal obesity. Thus, current study will be conducted to investigate effect of extracorporeal shockwave on abdominal adiposity and lipid profile in obese post-menopausal women.

Interventions

OTHERExtracorporeal Shockwave therapy

2000 shots, 120mJ pulse energy setting, 3 bar pressure, and 15 Hz for 15 minute per session.

OTHERBalanced low-calorie diet

1500 k/cal for 6 weeks

Sponsors

Cairo University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Masking description

Double masking (Investigator and Participant)

Intervention model description

Clinical randomized controlled study

Eligibility

Sex/Gender
FEMALE
Age
45 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Their age range 45-60 years old. * Their body mass index range 30-35 kg/m square. * Only, obese postmenopausal women with at least one year after stoppage of menses.

Exclusion criteria

* Receiving pharmacological treatment. * Receiving any form of electrotherapy. * Whom with metabolic, hematological or renal dysfunction. * Whom have dermatological or cardiovascular or respiratory, digestive or rheumatic disorders.

Design outcomes

Primary

MeasureTime frameDescription
Waist/ hip ratioPretreatment and Posttreatment of six weeks study protocol.anthropometric outcome measure for abdominal adiposity
Skin fold caliperPretreatment and Posttreatment of six weeks study protocol.subcutaneous fat outcome measure

Secondary

MeasureTime frameDescription
Lipid profilePretreatment and Posttreatment of six weeks study protocol.Low-density lipoprotein, High-density lipoprotein, and triglyceride laboratory outcome measures.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026